With the confirmation that the SRR124–134 cluster drives SOX2 overexpression in the BRCA and LUAD cell lines, we investigated chromatin accessibility at this enhancer cluster within primary tumors isolated from cancer patients. This evidence concerns the gene SOX2 and cancer.